Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can a Three Months Treatment With Oral Desogestrel Prior to Insertion of the Etonogestrel Subdermal Implant Improve Continuation Rate at One Year?

NCT05174195 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT05174195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05174195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can a Three Months Treatment With Oral Desogestrel Prior to Insertion of the Etonogestrel Subdermal Implant Improve Continuation Rate at One Year?
Lead sponsor
University Hospital, Geneva
Phase
Not applicable
Overall status
Terminated
Start date
August 15, 2016
Completion date
September 30, 2019
Enrollment
67 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contraception, progestogen adverse reaction